ɬÀï·¬

Lipid News

Crystal building blocks of triglycerides

Michael Airola
By Michael Airola
Dec. 1, 2019

Francis Crick once said, “If you want to understand function, study structure.” Do you agree? I certainly do, and I would argue that most lipid biologists do too. Just consider the effort to define chemical structures for the many thousands of lipids that exist and the hypotheses about individual lipid function that this structural information has generated.

What has lagged behind is the characterization of the structures of the proteins that modify, transport or interact with these lipids, but times are changing. For example, when I started my postdoc in lab, only a handful of sphingolipid-metabolizing enzymes had been structurally characterized, and these were mainly from bacteria. While many questions remain open (hey, ceramide synthase — we can’t wait to see what you look like!), work from several labs has defined the structures and mechanisms for many human enzymes in sphingolipid metabolism.

A similar revolution appears to be happening with triglycerides. As most of you know, triglycerides serve as a reservoir for energy storage, but when they accumulate excessively, they can cause health problems, including obesity, diabetes and heart disease. Three new structures in particular have caught my attention.

Chrystal structureBeautiful structures of proteins involved in triglyceride metabolism and storage.Michael Airola is a crystal structure of microsomal triglyceride transfer protein complex, which transfers neutral lipids into apolipoprotein B-containing lipoproteins. The arduous crystallography required to conduct this work is impressive. The researchers revealed an unexpected lipid-binding cavity and provided insight into disease mutations as well as pharmacological inhibition of this therapeutic target.

The second is the crystal structure of lipoprotein lipase, or LPL, the major lipase that clears triglycerides in the blood. and separately determined the LPL structures, overcoming the relative instability of LPL by complexing it with its binding partner glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1. These structures, along with other biochemical data, suggest LPL is active as a monomer, challenging the long-standing paradigm that LPL was only active as a dimer.

The last notable structure is that of seipin, a homo-oligomeric integral membrane protein that is a key player in the formation of cytoplasmic lipid droplets. Two groups ( and ), using cryo-electron microscopy, found that 11 or 12 seipin molecules (dependent on the species) come together to form a ring that spans the endoplasmic reticulum membrane, can bind phosphatidic acid and may stabilize the formation of nascent lipid droplets.

What’s next? Who knows, but I’m darn sure we’re all gonna love it.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Michael Airola
Michael Airola

Michael Airola is an assistant professor of biochemistry and cell biology at Stony Brook University.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Mapping the placenta’s hormone network
Journal News

Mapping the placenta’s hormone network

Oct. 21, 2025

Study uncovers how the placenta actively metabolizes not only glucocorticoids but also novel androgens and progesterones, reshaping our understanding of pregnancy and its complications.

Biochemists and molecular biologists sweep major 2025 honors
News

Biochemists and molecular biologists sweep major 2025 honors

Oct. 20, 2025

Recent Nobel, MacArthur and Kimberly Prize honorees highlight the power of biochemistry and molecular biology to drive discovery, including immune tolerance, vaccine design and metabolic disease, and to advance medicine and improve human health.

Spider-like proteins spin defenses to control immunity
News

Spider-like proteins spin defenses to control immunity

Oct. 17, 2025

Researchers from Utrecht University discovered two distinct binding modes of a spider-shaped immune inhibitor found in serum.

A biological camera: How AI is transforming retinal imaging
Feature

A biological camera: How AI is transforming retinal imaging

Oct. 15, 2025

AI is helping clinicians see a more detailed view into the eye, allowing them to detect diabetic retinopathy earlier and expand access through tele-ophthalmology. These advances could help millions see a clearer future.

AI in the lab: The power of smarter questions
Essay

AI in the lab: The power of smarter questions

Oct. 14, 2025

An assistant professor discusses AI's evolution from a buzzword to a trusted research partner. It helps streamline reviews, troubleshoot code, save time and spark ideas, but its success relies on combining AI with expertise and critical thinking.

Training AI to uncover novel antimicrobials
Feature

Training AI to uncover novel antimicrobials

Oct. 9, 2025

Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.